Spots Global Cancer Trial Database for TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES)
Official Title: TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES). Phase II Clinical Trial, Single Arm, Two Stage
Study ID: NCT02608411
Conditions
Interventions
Study Description
Brief Summary: This study aims to assess the role of MET inhibitors as maintenance treatment in adult patients with extensive stage small cell lung cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Istituto Oncologico Veneto, Padova, , Italy
Contact Details
Name: Giulia Pasello, MD
Affiliation: Istituto Oncologico Veneto IRCCS
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
